| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
2,376 |
1,888 |
$66K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,076 |
814 |
$13K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
196 |
194 |
$9K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
211 |
125 |
$7K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
239 |
146 |
$6K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
906 |
874 |
$5K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
325 |
322 |
$3K |
| 36415 |
Collection of venous blood by venipuncture |
1,105 |
1,037 |
$2K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
116 |
51 |
$2K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
48 |
27 |
$810.96 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
330 |
294 |
$763.71 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
13 |
12 |
$177.70 |
| 81003 |
|
272 |
262 |
$154.21 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
236 |
220 |
$138.54 |
| J3420 |
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg |
65 |
53 |
$91.99 |
| 3044F |
|
122 |
120 |
$0.61 |
| 3078F |
|
58 |
55 |
$0.27 |
| 3074F |
|
67 |
64 |
$0.27 |
| 1036F |
|
16 |
15 |
$0.01 |
| G8417 |
Bmi is documented above normal parameters and a follow-up plan is documented |
183 |
178 |
$0.00 |
| G8431 |
Screening for depression is documented as being positive and a follow-up plan is documented |
13 |
13 |
$0.00 |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
499 |
386 |
$0.00 |